Princess Margaret Hospital | GenomeWeb

Princess Margaret Hospital

Results from a recent study clarify some conflicting prior determinations, and provide a new rationale to further explore the FCGR2A biomarker in prospective trials.

The initial phase of GENIE, which stands for Genomics, Evidence, Neoplasia, Information, Exchange, involves seven founding members and two informatics partners.

Canada's Hospital for Sick Children and the University Health Network's Princess Margaret Cancer Centre are piloting a new IT infrastructure for analyzing genetic and other kinds of biomedical data.

This story has been updated to include additional information from a US survey on people's attitudes about cost of genetic testing. Originally published June 4.

OICR plans to validate the machine and develop a framework for sequencing patient tumors that can help physicians make informed decisions about treatments or clinical trial placements.

The company's most recent deal to apply its technology for assay development is "part of a broad program we have embarked on to exploit our unique ability to apply mass spectrometry to FFPE tissue," a company official said.

Pfizer enlisted the help of Ontario researchers to find molecular signatures that can be used to personalize treatments in its pipeline for colorectal cancer.

Founded in 2000 on technology developed at the Ontario Cancer Institute and University of Toronto, Molecular Templates had difficulty securing add-on funding in its home country following a $1.5 million investment earlier this decade.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.